Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin for severe non-hemorrhagic traumatic brain injury
IRCT20220521054939N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in traumatic brain injury (TBI) comparing Indomethacin with Placebo (2 arms). Primary endpoints: Arterial oxygen saturation, Arterial oxygen partial pressure and 4 more. Started Jul 2022; status: completed.
02
Drugs
indomethacin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20220521054939N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220521054939N1.